Lilly's Foundayo pill wins over a third of new patients, CEO says
CEO Dave Ricks also broke ground Monday on a $6.5 billion manufacturing plant in Houston that Lilly expects will be operational by 2030
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- STAT+: Lilly’s breast cancer combo wins approval statnews.com